Skip to main content

Table 1 Characteristics of included studies

From: Diabetes remission of bariatric surgery and nonsurgical treatments in type 2 diabetes patients who failure to meet the criteria for surgery: a systematic review and meta-analysis

Study

Year of publication

Sample size

Country

Design

Type of surgery

Medical therapy

Follow-up(Months)

Baseline mean BMI(kg/m2)

Definition of diabtes Remission

Daniel H et al

2020

57

America

Randomized Controlled Trial

RYGB(28%), LSG(62%) or LAGB(10%)

Medical weight management

36

32.8 (bariatric surgery) 32.0 (medical therapy)

Not reported

Keong C et al

2017

41

America

Randomized Controlled Trial

RYGB

Intensive medical management

41

32.9

Blood HbA1c < 6.5% (48 mmol/mol) or < 6% (42 mmol/mol) without any antihyperglycemic medication for at least 1-year duration, respectively

Wenhuan F et al

2018

40

China

Retrospective cohort study

RYGB

Weight management and antidiabetic agents

12

33.3 (bariatric surgery) 32.1 (medical therapy)

T2DM required HbA1c less than 6.0% and fasting blood glucose (FBG) less than 5.6 mmol/L, with no use of antidiabetic agents for 1 year

Chih-Cheng H et al

2015

351

China

Retrospective cohort study

LSG(36.5%) or GB(63.5%)

Medical treatment

60

31.0 (bariatric surgery) 29.1 (medical therapy)

HbA1c < 6.0% and 6.0%-6.5% of total hemoglobin [Hb; to convert to proportion of total Hb, multiply by 0.01], respectively, for those who were exempted from any antidiabetic drugs for 5 years

Mohit B et al

2017

70

India

Prospective study

RYGB

GLP-1

12

34.17 (bariatric surgery) 32.67 (GLP-1) 31.33(SGLT2)

Not reported

John M et al

2014

51

Australlia

Randomized Controlled Trial

LAGB

Multidisciplinary Diabetes Care

24

29.0 (bariatric surgery) 29.0 (medical therapy)

serum glucose values were ≤ 125 mg/dL and HbA1c ≤ 6.0%, on free diet and with no antidiabetic medical therapy, controlled when, under the same conditions, HbA1c was ≤ 7.0%, and improved when preoperative HbA1c was steadily reduced by at least 1% with less antidiabetic therapy

Bruno G et al

2012

36

America

Retrospective cohort study

DJB

standard medical care

12

26.1 (bariatric surgery) 26.3 (medical therapy)

Not reported

  1. RYGB Roux-en-Y gastric bypass, LSG Laparoscopic sleeve gastrectomy, LAGB Laparoscopic adjustable gastric banding, DJB Duodenal-jejunal bypass, GLP-1 Glucagon-like peptide-1 analogues